| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/05/2006 | US20060223121 Contacting biological sample of urine, cerebrospinal fluid or serum with a peptide and complexing with a monoclonal antibody ligand; detecting an immunogenic peptide having calgranulin B protein activity; Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis; rheumatoid arthritis |
| 10/05/2006 | US20060223119 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 10/05/2006 | US20060223117 Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof |
| 10/05/2006 | US20060223115 Heterotrimeric G-protein |
| 10/05/2006 | US20060223112 Novel receptor |
| 10/05/2006 | US20060223110 Drug design; use of machine-readable data storage media comprising structure coordinates of Site II |
| 10/05/2006 | US20060223109 G protein-coupled receptors |
| 10/05/2006 | US20060223096 Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 10/05/2006 | US20060223093 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 10/05/2006 | US20060223090 Polynucleotides encoding human secreted proteins |
| 10/05/2006 | US20060223088 Human secreted proteins |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060223077 207 human secreted proteins |
| 10/05/2006 | US20060223076 Cyanine dyes and their applications as luminescence quenching compounds |
| 10/05/2006 | US20060223063 Method of diagnosis of type 2 diabetes and early onset thereof |
| 10/05/2006 | US20060223055 Methods and compositions for treatment of viral lnfection |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222663 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/05/2006 | US20060222662 Composition to be administered to a living being and method for marking agents |
| 10/05/2006 | US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 10/05/2006 | US20060222658 Vaccinia virus nucleic acids, polypeptides and immunogenic compositions |
| 10/05/2006 | US20060222657 Polypeptide transduction and fusogenic peptides |
| 10/05/2006 | US20060222656 MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| 10/05/2006 | US20060222652 Molecular antigen array |
| 10/05/2006 | US20060222650 Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins |
| 10/05/2006 | US20060222649 Methods for inducing antigen-specific T cell tolerance |
| 10/05/2006 | US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1) |
| 10/05/2006 | US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof |
| 10/05/2006 | US20060222635 Methods and compositions for selecting cells with increased potency |
| 10/05/2006 | US20060222630 Internal ribosome entry site of the labial gene for protein expression |
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | US20060222626 enhancing the tumoricidal activity of an isolated TNF protein comprising bonding to the TNF to polyethyleneglycol; increased circulating half-life of the TNF while not increasing its toxicity; antitumor or anticarcinogenic agents with reduced side effects |
| 10/05/2006 | US20060222624 Detoxified TNF and method of preparing |
| 10/05/2006 | US20060222593 Peptide-chelate conjugates |
| 10/05/2006 | DE102005015043A1 Multilayer compound or coated substrate for sandwich foils packaging, comprises hydrophobin polypeptide as an adhesive agent arranged between two adjacent layers of the multilayer compound or between the coating and the substrate |
| 10/05/2006 | DE102005013846A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 10/05/2006 | CA2605160A1 Clostridial toxin activity assays |
| 10/05/2006 | CA2603374A1 Use of hydrophobin as a phase stabiliser |
| 10/05/2006 | CA2603325A1 Methods for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 10/05/2006 | CA2603298A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 10/05/2006 | CA2602763A1 Means for the inhibition of anti-.beta.1-adrenergic receptor antibodies |
| 10/05/2006 | CA2602463A1 High affinity hiv t cell receptors |
| 10/05/2006 | CA2598884A1 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/05/2006 | CA2593559A1 Polynucleotides encoding stem cell factor-like proteins |
| 10/04/2006 | EP1707641A2 Evolution of whole cells and organisms by recursive sequence recombination |
| 10/04/2006 | EP1707634A1 Method for isolation of recombinantly produced proteins |
| 10/04/2006 | EP1707633A1 Alphavirus vectors for paramyxovirus vaccines |
| 10/04/2006 | EP1707631A2 An improved method for the production and purification of adenoviral vectors |
| 10/04/2006 | EP1707629A1 Expression system with the use of mammalian beta-actin promoter |
| 10/04/2006 | EP1707575A1 Ligation of synthetic zincfinger peptides to serial zincfingerproteins for specific detection of double stranded DNA (zincfinger probes) |
| 10/04/2006 | EP1707574A1 Method for producing factor G derived from horseshoe crab (Limulus) |
| 10/04/2006 | EP1707573A1 Fractionator and method of fractionation |
| 10/04/2006 | EP1706745A1 Methods and means of screening for rhomboid activity |
| 10/04/2006 | EP1706721A2 Bacillus licheniformis chromosome |
| 10/04/2006 | EP1706499A2 Human cytomegalovirus us3 gene promoter |
| 10/04/2006 | EP1706498A2 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 10/04/2006 | EP1706494A2 Method for production of recombinant growth hormone in form of hybrid protein |
| 10/04/2006 | EP1706491A2 Toxin complex proteins and genes from xenorhabdus bovienii |
| 10/04/2006 | EP1706486A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 10/04/2006 | EP1706485A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS |
| 10/04/2006 | EP1706482A1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 10/04/2006 | EP1706481A2 Vaccine |
| 10/04/2006 | EP1706426A2 Nogoa antibodies for the treatment of alzheimer disease |
| 10/04/2006 | EP1706422A1 Nucleic acid encoding a guinea pig prostaglandin receptor protein and methods of use thereof |
| 10/04/2006 | EP1706421A2 Methods of modulating cytokine activity; related reagents |
| 10/04/2006 | EP1706420A1 Site-specific coupling of polypeptides |
| 10/04/2006 | EP1706419A2 Modified fusion peptides derived from a p53 domain against malignant and/or transformed mammalian cells |
| 10/04/2006 | EP1706418A2 Live genetically attenuated malaria vaccine |
| 10/04/2006 | EP1706417A1 A novel protein capable of inhibiting anthrax toxin activity |
| 10/04/2006 | EP1706416A2 Chimera botulinum toxin type e |
| 10/04/2006 | EP1706153A1 Minimal lentiviral vector system |
| 10/04/2006 | EP1706144A2 Medicament comprising inhibitors of long pentraxin ptx3 |
| 10/04/2006 | EP1706138A2 Methods for treating inflammation using thyroid stimulating hormone |
| 10/04/2006 | EP1706136A2 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 10/04/2006 | EP1706134A2 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 10/04/2006 | EP1706131A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 10/04/2006 | EP1705987A2 Proteins of nutraceutical and biotherapeutic potential |
| 10/04/2006 | EP1664300A4 A new class of a2delta calcium channel subunits |
| 10/04/2006 | EP1644496A4 Modified vectors for organelle transfection |
| 10/04/2006 | EP1588139A4 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 10/04/2006 | EP1558631A4 Methods and compositions for diagnosing and treating companion animal cancer |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1509336A4 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers |
| 10/04/2006 | EP1467746A4 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue |
| 10/04/2006 | EP1247094A4 ASSAYS FOR DETECTION OF i BACILLUS ANTHRACIS /i |
| 10/04/2006 | EP1169461B1 Use of pancreatic procarboxypeptidase B for the production of insulin |
| 10/04/2006 | EP1161537B1 Non-spreading pestivirus |
| 10/04/2006 | EP1082435B1 Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/04/2006 | EP1009832B1 Cytokine designated lerk-6 |
| 10/04/2006 | EP1003861B1 Mammalian cell membrane proteins; related reagents |
| 10/04/2006 | EP0986644B1 Production of erythropoietin by endogenous gene activation with viral promoters |
| 10/04/2006 | EP0977873B1 Method for cleavage of fusion proteins |
| 10/04/2006 | EP0964702B1 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 10/04/2006 | EP0957936B1 Formulations of recombinant papillomavirus vaccines |
| 10/04/2006 | EP0813597B1 A process for the purification of vitamin k dependent coagulation factors by chromatography |
| 10/04/2006 | EP0783525B1 Humanized antibodies against respiratory syncytial virus |
| 10/04/2006 | CN1842601A Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins |
| 10/04/2006 | CN1842599A Genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use |